CAS 98902-29-5
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 prodotti.
2,3,4,5-Tetradehydro Alfuzosin Hydrochloride
CAS:Formula:C19H24ClN5O4Purezza:95%Colore e forma:SolidPeso molecolare:421.8780N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloridePurezza:95%Peso molecolare:421.89g/molRef: ST-EA-CP-A71001
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta2,3,4,5-Tetradehydro Alfuzosin Hydrochloride
CAS:<p>Impurity Alfuzosin EP Impurity A / Alfuzosin USP Related Compound A<br>Stability Hygroscopic<br>Applications 2,3,4,5-Tetradehydro Alfuzosin Hydrochloride (Alfuzosin EP Impurity A) is an impurity of Alfuzosin (A532010) . Alfuzosin (A532010) is an α1-adrenoceptor antagonist with antihypertensive activity.<br>References Manoury, P.M. et al.: J. Med. Chem., 29, 19 (1986);<br></p>Formula:C19H23N5O4·ClHColore e forma:NeatPeso molecolare:421.882,3,4,5-Tetradehydro alfuzosin hydrochloride
CAS:<p>Alfuzosin is a potent, selective, and long-acting α1A-adrenergic receptor antagonist. It is used to treat benign prostatic hyperplasia (BPH) in males. Alfuzosin is also used as an antihypertensive agent, for the treatment of pheochromocytoma, and for the treatment of benign prostatic hyperplasia in males. The hydrogenation of 2,3,4,5-tetradehydroalfuzosin to alfuzosin hydrochloride is performed by liquid hydrogenation or by hydrogenation on a palladium catalyst in a mixture of dimethylformamide and hexamethylphosphoramide. This process minimizes the formation of impurities such as 2,3,4-trimethoxy alfuzosin.</p>Formula:C19H24ClN5O4Purezza:Min. 95%Colore e forma:White PowderPeso molecolare:421.88 g/mol
![N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]furan-2-carboxamide Hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb%2FMM1004.01-0025.jpg&w=3840&q=75)
